Catechol-substituted phenoxypropanolamines: adrenoceptor activity in the anaesthetized cat

Area of Science:

• Pharmacology
• Medicinal Chemistry

Background:

• Adrenergic compounds like noradrenaline and adrenaline are crucial in regulating physiological functions.
• Understanding structure-activity relationships is key to developing selective adrenoceptor modulators.

Purpose of the Study:

• To compare the pharmacological actions of novel oxymethylene (OXY)-linked adrenergic derivatives with their parent compounds.
• To investigate the impact of the OXY linkage on adrenoceptor selectivity and potency.

Main Methods:

• Pharmacological testing in anesthetized cats.
• Evaluation of chronotropic effects, bronchodilation, hind limb perfusion pressure, and soleus muscle contractions.
• Comparison of OXY-derivatives with racemic noradrenaline, adrenaline, isoprenaline, and N-t-butylnoradrenaline.

Main Results:

• All OXY-derivatives demonstrated potent beta-adrenoceptor agonist activity.
• The oxymethylene linkage conferred selectivity for beta1 over beta2 adrenoceptors.
• OXY-derivatives of adrenaline and noradrenaline exhibited significantly weaker alpha-adrenoceptor stimulant effects compared to parent compounds.

Conclusions:

• The oxymethylene linkage is a valuable modification for enhancing beta-adrenoceptor agonist potency and beta1 selectivity.
• OXY-derivatives represent a promising class of compounds with potential for targeted adrenergic therapies.
• This structural modification reduces unwanted alpha-adrenoceptor stimulation.